|
Market Cap | 631.10M | EPS (ttm) | -1.32 |
P/E | - | EPS this Y | 54.13% |
Forward P/E | - | EPS next Y | 55.00% |
PEG | - | EPS past 5Y | -8.72% |
P/S | 59.20 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -17.44% |
Dividend | - | Sales Q/Q | - |
Insider Own | 30.16% | Inst Own | 56.10% |
Insider Trans | -3.61% | Inst Trans | -6.30% |
Short Float | 5.86% | Earnings | Mar 06/b |
Analyst Recom | 1.25 | Target Price | 11.50 |
Avg Volume | 2.22M | 52W Range | 0.76 - 9.39 |
|
|
|
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Shendelman Shoshana | President and CEO | Mar 14 '24 | Sale | 5.39 | 318,573 | 1,717,108 | 3,817,814 | Mar 18 06:12 PM | Perfetti Riccardo | Chief Medical Officer | Mar 14 '24 | Sale | 5.39 | 110,804 | 597,234 | 1,031,537 | Mar 18 06:02 PM | Hansard Adam | Chief Commercial Officer | Mar 14 '24 | Sale | 5.39 | 48,871 | 263,415 | 732,919 | Mar 18 06:00 PM | Funtleyder Leslie D. | Chief Financial Officer | Mar 14 '24 | Sale | 5.39 | 28,727 | 154,839 | 308,421 | Mar 18 05:57 PM | Kanter Stacy J. | Director | Dec 01 '23 | Buy | 2.18 | 30,000 | 65,367 | 63,000 | Dec 05 07:03 PM |
|
|
|
|
Market Cap | 820.89M | EPS (ttm) | -0.75 |
P/E | - | EPS this Y | 60.80% |
Forward P/E | 195.20 | EPS next Y | 134.69% |
PEG | - | EPS past 5Y | -57.58% |
P/S | 2.32 | EPS next 5Y | 2.00% |
P/B | 2.90 | EPS Q/Q | -281.61% |
Dividend | - | Sales Q/Q | 17.98% |
Insider Own | 6.15% | Inst Own | 86.71% |
Insider Trans | -8.16% | Inst Trans | 4.35% |
Short Float | 6.96% | Earnings | Feb 15/a |
Analyst Recom | 1.00 | Target Price | 25.15 |
Avg Volume | 233.19K | 52W Range | 11.60 - 20.49 |
|
|
|
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GREEN ANDREW M | VP Regulatory | Mar 15 '24 | Sale | 20.00 | 1,462 | 29,240 | 41,121 | Mar 18 06:09 PM | GREEN ANDREW M | VP Regulatory | Mar 14 '24 | Sale | 20.00 | 3,994 | 79,880 | 42,583 | Mar 15 05:20 PM | Getz Matthew A | VP, Human Resources | Mar 12 '24 | Sale | 19.94 | 5,000 | 99,720 | 43,536 | Mar 14 09:06 PM | Mackin James P | President & CEO | Mar 05 '24 | Sale | 18.72 | 13,996 | 262,037 | 705,562 | Mar 07 06:20 PM | Holloway Jean F | SVP, General Counsel | Mar 05 '24 | Sale | 18.72 | 2,380 | 44,559 | 169,669 | Mar 07 06:16 PM |
|
|
|
|
Market Cap | 3.54B | EPS (ttm) | -0.65 |
P/E | - | EPS this Y | 88.95% |
Forward P/E | - | EPS next Y | 29.21% |
PEG | - | EPS past 5Y | - |
P/S | 4.02 | EPS next 5Y | 0.21% |
P/B | 1.45 | EPS Q/Q | 11256.00% |
Dividend | 4.21% | Sales Q/Q | 3.80% |
Insider Own | 0.79% | Inst Own | 88.52% |
Insider Trans | -3.29% | Inst Trans | -3.20% |
Short Float | 6.14% | Earnings | Feb 07/b |
Analyst Recom | 3.57 | Target Price | 15.71 |
Avg Volume | 2.03M | 52W Range | 8.57 - 17.69 |
|
|
|
Macerich Co. operates as a real estate investment trust, which engages in the acquisition, ownership, development, redevelopment, management, and leasing of regional and community shopping centers located throughout the United States. The company was founded by Mace Siegel Dana K. Anderson, Arthur M. Coppola and Edward C. Coppola in 1964 and is headquartered in Santa Monica, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
O HERN THOMAS E | Director | Mar 14 '24 | Sale | 16.39 | 7,964 | 130,530 | 0 | Mar 18 06:09 PM | COPPOLA EDWARD C | President | Feb 20 '24 | Sale | 17.20 | 50,000 | 860,045 | 655,667 | Feb 22 07:28 PM |
|
|
| |
|
Market Cap | 6.92B | EPS (ttm) | 3.66 |
P/E | 33.42 | EPS this Y | 13.00% |
Forward P/E | 20.69 | EPS next Y | 9.55% |
PEG | 2.23 | EPS past 5Y | 16.56% |
P/S | 1.89 | EPS next 5Y | 15.00% |
P/B | 4.64 | EPS Q/Q | -65.31% |
Dividend | 0.19% | Sales Q/Q | 22.69% |
Insider Own | 3.56% | Inst Own | 97.24% |
Insider Trans | -6.70% | Inst Trans | 0.11% |
Short Float | 6.58% | Earnings | Feb 01/a |
Analyst Recom | 1.50 | Target Price | 132.00 |
Avg Volume | 264.34K | 52W Range | 87.14 - 127.57 |
|
|
|
The Ensign Group, Inc. engages in providing skilled nursing, senior living, and rehabilitative care services. It operates through the Skilled Services and Standard Bearer segments. The Skilled Services segments includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment refers to the leasing to skilled nursing and senior living operations. The company was founded by Roy E. Christensen, Christopher R. Christensen, and Gregory K. Stapley in 1999 and is headquartered in San Juan Capistrano, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Wittekind Beverly B. | VP and General Counsel | Mar 14 '24 | Option Exercise | 17.23 | 8,258 | 142,262 | 47,912 | Mar 18 06:08 PM | Wittekind Beverly B. | VP and General Counsel | Mar 14 '24 | Sale | 121.65 | 10,000 | 1,216,549 | 37,912 | Mar 18 06:08 PM | Shaw Daren | Director | Feb 15 '24 | Option Exercise | 10.89 | 4,000 | 43,560 | 37,375 | Feb 20 05:18 PM | Shaw Daren | Director | Feb 15 '24 | Sale | 119.67 | 6,000 | 718,005 | 31,375 | Feb 20 05:18 PM | Christensen Christopher R. | Executive Chairman | Feb 08 '24 | Sale | 117.56 | 10,800 | 1,269,616 | 147,400 | Feb 08 07:40 PM |
|
|
|
|
Market Cap | 9.39B | EPS (ttm) | 0.74 |
P/E | 108.81 | EPS this Y | -481.44% |
Forward P/E | - | EPS next Y | 28.68% |
PEG | - | EPS past 5Y | - |
P/S | 0.87 | EPS next 5Y | - |
P/B | 37.98 | EPS Q/Q | 86.87% |
Dividend | - | Sales Q/Q | -14.56% |
Insider Own | 17.18% | Inst Own | 98.05% |
Insider Trans | -0.42% | Inst Trans | 1.15% |
Short Float | 34.79% | Earnings | Feb 22/a |
Analyst Recom | 3.14 | Target Price | 62.30 |
Avg Volume | 7.72M | 52W Range | 6.63 - 90.48 |
|
|
|
Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
JENKINS MARK W. | Chief Financial Officer | Mar 15 '24 | Sale | 79.37 | 5,000 | 396,850 | 183,156 | Mar 18 06:06 PM | BREAUX PAUL W. | See Remarks | Mar 08 '24 | Sale | 89.00 | 20,000 | 1,780,000 | 115,032 | Mar 11 06:26 PM | PARIKH NEHA | Director | Mar 05 '24 | Buy | 76.68 | 1,300 | 99,684 | 59,795 | Mar 06 05:34 PM | Palmer Stephen R | Vice President of Accounting | Mar 04 '24 | Sale | 80.62 | 474 | 38,214 | 67,514 | Mar 05 05:50 PM | GILL DANIEL J. | Chief Product Officer | Mar 04 '24 | Sale | 80.62 | 137 | 11,045 | 402,373 | Mar 05 05:49 PM |
|
|
| |
|
Market Cap | 21.74B | EPS (ttm) | 3.49 |
P/E | 17.91 | EPS this Y | 30.49% |
Forward P/E | 13.21 | EPS next Y | -0.95% |
PEG | - | EPS past 5Y | - |
P/S | 1.40 | EPS next 5Y | - |
P/B | 7.76 | EPS Q/Q | 12.98% |
Dividend | 1.38% | Sales Q/Q | -21.35% |
Insider Own | 1.04% | Inst Own | 98.73% |
Insider Trans | -6.64% | Inst Trans | -4.89% |
Short Float | 3.41% | Earnings | Feb 28/b |
Analyst Recom | 1.44 | Target Price | 60.25 |
Avg Volume | 4.32M | 52W Range | 22.67 - 63.22 |
|
|
|
Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, Sunset, and Asset Closure. The Retail segment sells electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Sunset segment includes generation plants with announced retirement plans. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Kirby Carrie Lee | EVP and Chief Admin. Officer | Mar 14 '24 | Option Exercise | 23.08 | 72,748 | 1,679,384 | 223,946 | Mar 18 06:04 PM | Kirby Carrie Lee | EVP and Chief Admin. Officer | Mar 14 '24 | Sale | 62.63 | 72,748 | 4,555,850 | 184,201 | Mar 18 06:04 PM | HUDSON SCOTT A | EVP & President Vistra Retail | Mar 12 '24 | Option Exercise | 16.35 | 86,517 | 1,414,740 | 300,195 | Mar 14 04:53 PM | HUDSON SCOTT A | EVP & President Vistra Retail | Mar 12 '24 | Sale | 59.11 | 86,517 | 5,114,411 | 254,932 | Mar 14 04:53 PM | Moore Stephanie Zapata | EVP and General Counsel | Mar 05 '24 | Option Exercise | 24.43 | 98,020 | 2,394,787 | 220,163 | Mar 07 08:08 PM |
|
|
|
|
Market Cap | 10.50B | EPS (ttm) | -2.49 |
P/E | - | EPS this Y | 29.75% |
Forward P/E | - | EPS next Y | 26.97% |
PEG | - | EPS past 5Y | -58.94% |
P/S | 5.48 | EPS next 5Y | - |
P/B | 3.97 | EPS Q/Q | 50.58% |
Dividend | - | Sales Q/Q | 47.94% |
Insider Own | 20.44% | Inst Own | 70.27% |
Insider Trans | -4.63% | Inst Trans | 4.91% |
Short Float | 12.08% | Earnings | Feb 08/a |
Analyst Recom | 2.82 | Target Price | 39.56 |
Avg Volume | 13.69M | 52W Range | 8.80 - 52.48 |
|
|
|
Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Rabois Keith | Director | Mar 14 '24 | Sale | 34.39 | 9,276 | 318,970 | 78,552 | Mar 18 06:01 PM | Adkins Katherine | Chief Legal Officer | Mar 01 '24 | Option Exercise | 0.00 | 6,782 | 0 | 99,920 | Mar 05 06:01 PM | Michalek Libor | President | Mar 01 '24 | Option Exercise | 0.00 | 2,336 | 0 | 137,328 | Mar 05 06:01 PM | Jiyane Siphelele | Vice President, Controller | Mar 01 '24 | Option Exercise | 0.00 | 9,495 | 0 | 201,565 | Mar 05 06:02 PM | Linford Michael | Chief Financial Officer | Mar 01 '24 | Option Exercise | 0.00 | 2,336 | 0 | 109,260 | Mar 05 06:01 PM |
|
|
| |
|
Market Cap | 1.70B | EPS (ttm) | 1.84 |
P/E | 24.18 | EPS this Y | 10.33% |
Forward P/E | 18.71 | EPS next Y | 17.24% |
PEG | 1.34 | EPS past 5Y | 8.78% |
P/S | 1.33 | EPS next 5Y | 18.00% |
P/B | 6.64 | EPS Q/Q | 10.30% |
Dividend | 1.91% | Sales Q/Q | 22.88% |
Insider Own | 82.58% | Inst Own | 31.37% |
Insider Trans | -3.50% | Inst Trans | -0.81% |
Short Float | 2.12% | Earnings | Feb 29/a |
Analyst Recom | 3.00 | Target Price | 48.00 |
Avg Volume | 84.43K | 52W Range | 20.52 - 45.94 |
|
|
|
Global Industrial Co. engages in direct marketing of brand name and private label industrial and business equipment and supplies. It sells an array of industrial and general business hard goods and supplies and to a lesser extent products that would fall into the generally recognizable category of maintenance, repair and operational ("MRO") products. The company was founded by Paul Leeds and Michael Leeds in 1949 and is headquartered in Port Washington, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
LEEDS BRUCE | Vice Chairman | Mar 14 '24 | Sale | 41.15 | 380,000 | 15,637,000 | 139,800 | Mar 18 05:59 PM | LEEDS ROBERT | Vice Chairman | Mar 14 '24 | Sale | 41.15 | 380,000 | 15,637,000 | 139,800 | Mar 18 05:57 PM | LEEDS RICHARD | Executive Chairman | Mar 14 '24 | Sale | 41.15 | 380,000 | 15,637,000 | 139,800 | Mar 18 05:56 PM | AXMACHER THOMAS | VP & Controller | Nov 09 '23 | Sale | 35.92 | 682 | 24,501 | 3,749 | Nov 13 06:42 PM |
|
|
|
|
Market Cap | 74.96M | EPS (ttm) | -1.89 |
P/E | - | EPS this Y | -0.20% |
Forward P/E | - | EPS next Y | -2.02% |
PEG | - | EPS past 5Y | -57.97% |
P/S | - | EPS next 5Y | - |
P/B | 0.83 | EPS Q/Q | -2.73% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 27.59% | Inst Own | 55.17% |
Insider Trans | -10.12% | Inst Trans | -2.76% |
Short Float | 12.66% | Earnings | Mar 01/b |
Analyst Recom | 1.89 | Target Price | 15.00 |
Avg Volume | 448.39K | 52W Range | 1.90 - 14.29 |
|
|
|
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cormorant Asset Management, LP | 10% Owner | Mar 15 '24 | Sale | 2.14 | 400,000 | 856,400 | 3,295,273 | Mar 18 05:59 PM | Cormorant Asset Management, LP | 10% Owner | Mar 14 '24 | Sale | 3.72 | 509,091 | 1,892,603 | 3,695,273 | Mar 18 05:59 PM |
|
|
|
|
Market Cap | 17.72B | EPS (ttm) | -2.18 |
P/E | - | EPS this Y | 42.12% |
Forward P/E | 40.57 | EPS next Y | 14.78% |
PEG | - | EPS past 5Y | -13.20% |
P/S | 7.83 | EPS next 5Y | 25.00% |
P/B | 3.01 | EPS Q/Q | 72.27% |
Dividend | - | Sales Q/Q | 18.63% |
Insider Own | 6.07% | Inst Own | 78.60% |
Insider Trans | -0.50% | Inst Trans | 0.21% |
Short Float | 2.37% | Earnings | Feb 28/a |
Analyst Recom | 2.19 | Target Price | 114.18 |
Avg Volume | 2.31M | 52W Range | 65.04 - 114.50 |
|
|
|
Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, API access management, authentication, user management, and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ARCHAMBEAU SHELLYE L | Director | Mar 14 '24 | Sale | 106.96 | 5,000 | 534,812 | 6,042 | Mar 18 05:59 PM | Ninan Shibu | Chief Accounting Officer | Feb 16 '24 | Sale | 90.23 | 2,500 | 225,575 | 6,539 | Feb 21 05:17 PM | Schwartz Larissa | See Remarks | Jan 16 '24 | Sale | 82.83 | 872 | 72,228 | 22,125 | Jan 18 06:37 AM | McKinnon Todd | Chief Executive Officer | Dec 18 '23 | Sale | 83.33 | 7,449 | 620,730 | 43,006 | Dec 19 05:07 PM | Tighe Brett | Chief Financial Officer | Dec 18 '23 | Sale | 83.33 | 4,816 | 401,320 | 63,565 | Dec 19 05:13 PM |
|
|
|